GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » Operating Cash Flow per Share

Adcock Ingram Holdings (JSE:AIP) Operating Cash Flow per Share : R3.63 (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings Operating Cash Flow per Share?

Adcock Ingram Holdings's operating cash flow per share for the six months ended in Dec. 2023 was R0.57. Adcock Ingram Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was R3.63.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Adcock Ingram Holdings was 284.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -9.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Adcock Ingram Holdings's Operating Cash Flow per Share or its related term are showing as below:

JSE:AIP' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -14.5   Med: 2.6   Max: 9.4
Current: -9

During the past 13 years, Adcock Ingram Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 9.40% per year. The lowest was -14.50% per year. And the median was 2.60% per year.

JSE:AIP's 3-Year OCF Growth Rate is ranked worse than
71.38% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs JSE:AIP: -9.00

Adcock Ingram Holdings Operating Cash Flow per Share Historical Data

The historical data trend for Adcock Ingram Holdings's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Operating Cash Flow per Share Chart

Adcock Ingram Holdings Annual Data
Trend Sep13 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.04 3.09 1.98 3.99 2.33

Adcock Ingram Holdings Semi-Annual Data
Mar14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.38 1.63 -0.68 3.05 0.57

Competitive Comparison of Adcock Ingram Holdings's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's Price-to-Operating-Cash-Flow falls into.



Adcock Ingram Holdings Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Adcock Ingram Holdings's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )=Cash Flow from Operations (A: Jun. 2023 )/Shares Outstanding (Diluted Average) (A: Jun. 2023 )
=381.752/163.754
=2.33

Adcock Ingram Holdings's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=89.743/156.455
=0.57

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R3.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings (JSE:AIP) Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.